• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON GMBH PLATE COLUMBIA CNA AG 5PRCT SB 90MM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON GMBH PLATE COLUMBIA CNA AG 5PRCT SB 90MM Back to Search Results
Catalog Number 254072
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/31/2020
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used.Initial reporter phone#: (b)(6).A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
The customer reported slow growth of staphylococcus aureus strains isolated from patient samples when using the plate columbia cna ag 5prct sb 90mm.The same strains have a good growth on columbia blood agar without cna and on another lot of columbia blood agar with cna.The event occurred on 10 occasions.There was no report of patient impact.
 
Event Description
The customer reported slow growth of staphylococcus aureus strains isolated from patient samples when using the plate columbia cna ag 5prct sb 90mm.The same strains have a good growth on columbia blood agar without cna and on another lot of columbia blood agar with cna.The event occurred on 10 occasions.There was no report of patient impact.
 
Manufacturer Narrative
H.6.Investigation: this statement is to summarize findings of a complaint against columbia cna agar with 5% sheep blood, catalog number 254072, lot number 0294956.Event description: it was reported that staph aureus would be discordant.Complaint history review: the complaints trends were reviewed.There were no similar complaints received during that period on this product lot.Therefore, a trend could not be identified.Batch history record (bhr) review: the batch history review did not indicate any discrepancies.All release testing was satisfactory, and no deviations were observed.Sample analysis: pictures were provided plates with growth.An analysis of growth promotion for the media was performed on retention samples for batch 0294956.The performance tests on retention samples of the above mentioned batch resulted in excellent growth of the following strains: str.Pyogenes atcc 19615, str.Pneumoniae atcc 6305, staph.Aureus atcc 25923, e.Faecalis atcc 29212, e.Coli atcc 25922.After an incubation time of 1 day at 36°c ± 1°c in co2 atmosphere.Evaluation results: at this stage of our investigation, we have excluded any systemic failure in our production process.No deviation could be found during the qc performance test.During this test, all strains referenced in the ifu were tested.However, lactobacillus was not referenced in the ifu.Investigation conclusion: based on the evaluation of the report and based on the qc test results, the complaint was not confirmed.A corrective and preventive action will not be implemented as a trend could not be identified.A definite root cause could not be determined.We would suggest that any prepared plated media be set aside and not use that does not meet the appearance specification as it is described on the bd certificate of analysis.This is consistent with industry recommendations for inspection of culture media prior to use (e.G.¿good practices for pharmaceutical microbiology laboratories¿, who technical report series, no.961, 2011, annex 2; chapter <1117> ¿microbiology best laboratory practices¿ the united states pharmacopeia; and the difco & bbl manual).H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLATE COLUMBIA CNA AG 5PRCT SB 90MM
Type of Device
NA
Manufacturer (Section D)
BECTON DICKINSON GMBH
8-12 tullastrasse
heidelberg 69126
GM  69126
Manufacturer (Section G)
BECTON DICKINSON GMBH
8-12 tullastrasse
heidelberg 69126
GM   69126
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key11219638
MDR Text Key256144476
Report Number9680577-2021-00001
Device Sequence Number1
Product Code JSI
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date01/13/2021
Device Catalogue Number254072
Device Lot Number0294956
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/31/2020
Initial Date FDA Received01/22/2021
Supplement Dates Manufacturer Received11/05/2021
Supplement Dates FDA Received11/16/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/20/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-